docetaxel anhydrous has been researched along with c.i. 42510 in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (c.i. 42510) | Trials (c.i. 42510) | Recent Studies (post-2010) (c.i. 42510) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 4,960 | 190 | 1,366 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, S; Bear, HD; Brown, A; Caldwell, CB; Fisher, B; Julian, T; Mamounas, EP; Mikkelson, WM; Miller, B; Robidoux, A; Smith, R; Soran, A; Sovan, A; Stauffer, JS; Theoret, H; Walker, AP; Wickerham, DL; Wolmark, N | 1 |
1 trial(s) available for docetaxel anhydrous and c.i. 42510
| Article | Year |
|---|---|
Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Colloids; Cyclophosphamide; Docetaxel; Doxorubicin; False Negative Reactions; Female; Humans; Lymph Node Excision; Middle Aged; Neoadjuvant Therapy; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Taxoids | 2005 |